Predictive factors for successful imatinib cessation in chronic myeloid leukemia patients treated with imatinib.
Lee SE; Choi SY; Bang JH; Kim SH; Jang EJ; Byeun JY; Park JE; Jeon HR; Oh YJ; Kim HJ; Kim YK; Park JS; Jeong SH; Kim SH; Zang DY; Oh S; Koo DH; Kim H; Do YR; Kwak JY; Kim JA; Kim DY; Mun YC; Mauro MJ; Kim DW; American Journal Of Hematology, 2013, vol. 88, issue 6, p 449, ISSN 10968652. ISBN 10968652.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef